Lavecaps (Lavender Oil)

Lavender oil’s primary constituents, linalool and linalyl acetate, are believed to influence the central nervous system by modulating GABA‑A receptors, which can produce calming effects. Additionally, these compounds exhibit mild anti‑inflammatory activity that may help soothe gastrointestinal irritation, contributing to the product’s overall supportive profile.

The appropriate dose of Lavecaps is determined by the prescribing healthcare professional based on individual needs, age, and health status. Because dosing can vary, patients should follow the specific instructions provided by their clinician or the product label.

Safety data for oral lavender oil during pregnancy and lactation are limited. It is advisable to avoid routine use unless a healthcare provider determines that the potential benefits outweigh any possible risks. Pregnant or nursing individuals should discuss any intended use with their physician.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, requesting verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details, and any necessary import documentation.

Lavecaps delivers lavender oil in an oral format, whereas many alternative products are available as essential‑oil aromatherapy or topical preparations. Oral delivery provides systemic exposure, which may differ in onset and duration of effect compared with inhalation or topical use. Choice of product depends on personal preference, intended use, and guidance from a healthcare professional.

Lavecaps should be stored at room temperature, ideally below 25 °C. Keep the container tightly closed, protect it from moisture, direct sunlight, and extreme heat. Do not refrigerate or freeze the product unless specifically instructed on the label.

Lavecaps is taken orally, typically with water. The exact administration schedule—such as timing relative to meals—should follow the prescribing clinician’s guidance or the instructions on the product label.

While most users experience no severe problems, rare but serious reactions can include anaphylaxis, significant liver enzyme elevation, and, in very uncommon cases, seizure activity. Anyone experiencing symptoms such as difficulty breathing, swelling of the face or throat, or persistent vomiting should seek immediate medical attention.

Individuals with a known allergy to lavender or other members of the Lamiaceae family should avoid Lavecaps. It is also contraindicated for patients taking anticoagulant therapy or strong central nervous system depressants without medical supervision, and for children unless specifically directed by a qualified healthcare provider.